These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8441167)

  • 1. The longterm prognosis of lupus nephritis: the impact of disease activity.
    Goulet JR; MacKenzie T; Levinton C; Hayslett JP; Ciampi A; Esdaile JM
    J Rheumatol; 1993 Jan; 20(1):59-65. PubMed ID: 8441167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
    Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.
    Faurschou M; Starklint H; Halberg P; Jacobsen S
    J Rheumatol; 2006 Aug; 33(8):1563-9. PubMed ID: 16881113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature.
    Esdaile JM; Levinton C; Federgreen W; Hayslett JP; Kashgarian M
    Q J Med; 1989 Sep; 72(269):779-833. PubMed ID: 2694209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefit of early treatment with immunosuppressive agents in lupus nephritis.
    Esdaile JM; Joseph L; MacKenzie T; Kashgarian M; Hayslett JP
    J Rheumatol; 1994 Nov; 21(11):2046-51. PubMed ID: 7869308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors in children with lupus nephritis].
    Wikiera-Magott I; Medyńska A; Zwolińska D
    Wiad Lek; 2005; 58 Suppl 1():50-4. PubMed ID: 16060085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longterm followup of childhood lupus nephritis.
    Hagelberg S; Lee Y; Bargman J; Mah G; Schneider R; Laskin C; Eddy A; Gladman D; Urowitz M; Hebert D; Silverman E
    J Rheumatol; 2002 Dec; 29(12):2635-42. PubMed ID: 12465165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.
    Fraenkel L; MacKenzie T; Joseph L; Kashgarian M; Hayslett JP; Esdaile JM
    J Rheumatol; 1994 Nov; 21(11):2052-7. PubMed ID: 7869309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of lupus nephritis in Indian children.
    Hari P; Bagga A; Mahajan P; Dinda A
    Lupus; 2009 Apr; 18(4):348-54. PubMed ID: 19276303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term outcome of 93 patients with proliferative lupus nephritis.
    Moroni G; Quaglini S; Gallelli B; Banfi G; Messa P; Ponticelli C
    Nephrol Dial Transplant; 2007 Sep; 22(9):2531-9. PubMed ID: 17510096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor prognostic factors of lupus nephritis.
    Kammoun K; Jarraya F; Bouhamed L; Kharrat M; Makni S; Hmida MB; Makni H; Kaddour N; Boudawara T; Bahloul Z; Hachicha J
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):727-32. PubMed ID: 21743218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
    Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
    Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease.
    Vu TV; Escalante A
    J Rheumatol; 1999 Dec; 26(12):2595-601. PubMed ID: 10606368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications.
    Gladman DD; Tandon A; Ibañez D; Urowitz MB
    J Rheumatol; 2010 Apr; 37(4):754-8. PubMed ID: 20231194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
    Demircin G; Oner A; Erdoğan O; Delibaş A; Baysun S; Bülbül M; Bek K; Oksal A
    Ren Fail; 2008; 30(6):603-9. PubMed ID: 18661410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of lupus nephritis activity using urinary retinol-binding protein.
    Sesso R; Rettori R; Nishida S; Sato E; Ajzen H; Pereira AB
    Nephrol Dial Transplant; 1994; 9(4):367-71. PubMed ID: 8084448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history and treatment of lupus nephritis.
    Austin HA; Balow JE
    Semin Nephrol; 1999 Jan; 19(1):2-11. PubMed ID: 9952276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.